Cargando…
COVID-19 and diffusing capacity of the lungs for carbon monoxide: a clinical biomarker in postacute care settings
Autores principales: | Fuschillo, Salvatore, Ambrosino, Pasquale, Motta, Andrea, Maniscalco, Mauro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Future Medicine Ltd
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8120998/ https://www.ncbi.nlm.nih.gov/pubmed/33988464 http://dx.doi.org/10.2217/bmm-2021-0134 |
Ejemplares similares
-
Metabolomics of COPD Pulmonary Rehabilitation Outcomes via Exhaled Breath Condensate
por: Maniscalco, Mauro, et al.
Publicado: (2022) -
Can FeNO be a biomarker in the post-COVID-19 patients monitoring?
por: Maniscalco, Mauro, et al.
Publicado: (2022) -
Performance of fractional exhaled nitric oxide in predicting response to inhaled corticosteroids in chronic cough: a meta-analysis
por: Ambrosino, Pasquale, et al.
Publicado: (2021) -
Fractional Exhaled Nitric Oxide (FeNO) in Patients with Stable Chronic Obstructive Pulmonary Disease: Short-Term Variability and Potential Clinical Implications
por: Ambrosino, Pasquale, et al.
Publicado: (2022) -
A Rapid Antigen Detection Test to Diagnose SARS-CoV-2 Infection Using Exhaled Breath Condensate by A Modified Inflammacheck(®) Device
por: Maniscalco, Mauro, et al.
Publicado: (2021)